BioNTech SE - American Depositary Shares (NQ:BNTX)

96.90 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

73 74 Next >

BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 16, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Cut Your Losses: Sell These 7 Weak Stocks Now ↗

October 16, 2023

You can't let weakness in a company or the market damage your portfolio. Avoid disappointing returns by moving on these stocks to sell.

Via InvestorPlace

Is Novavax Stock a Buy Now? ↗

October 16, 2023

Is this company just a pandemic stock?

Via The Motley Fool

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

October 16, 2023

From BioNTech SE

Via GlobeNewswire

Price Over Earnings Overview: BioNTech ↗

October 13, 2023

Via Benzinga

A Look Into BioNTech Inc's Price Over Earnings ↗

October 12, 2023

Via Benzinga

Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry ↗

October 05, 2023

Via Benzinga

Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs

October 16, 2023

From BioNTech SE

Via GlobeNewswire

Week In Review: Two China Biopharmas Announce Billion Dollar Deals ↗

October 14, 2023

MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...

Via Talk Markets

The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments? ↗

October 11, 2023

Vaccine revenue may have slipped but could still represent billions of dollars for these companies.

Via The Motley Fool

7 Innovator Stocks Primed for Exceptional Growth ↗

October 10, 2023

These featured, inventive companies are not only transforming old sectors but also building bridges toward new ones.

Via InvestorPlace

Privatized Vaccine Distribution Sparks Confusion, Payment Challenges ↗

October 09, 2023

As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.

Via Benzinga

Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute ↗

October 05, 2023

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin

Via Benzinga

Topics Intellectual Property Lawsuit

Why Novavax Stock Fell Today ↗

October 04, 2023

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...

Via Benzinga

Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares ↗

October 04, 2023

3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.

Via Benzinga

Short Sellers Are Betting Against Novavax (NVAX) Stock ↗

October 04, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

Via InvestorPlace

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna ↗

October 03, 2023

The company can now join Pfizer and Moderna in launching an updated booster in the U.S.

Via Investor's Business Daily

Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? ↗

October 03, 2023

Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S.

Via Benzinga

Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19 ↗

October 02, 2023

Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks.

Via Benzinga

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street ↗

October 01, 2023

Analysts like these stocks for very good reasons.

Via The Motley Fool

Why Pfizer and BioNTech Stocks Zoomed Higher Today ↗

September 29, 2023

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Via The Motley Fool

Why CureVac Stock Plunged Today ↗

September 29, 2023

A German court temporarily suspended proceedings in CureVac's IP lawsuit against BioNTech.

Via The Motley Fool

Topics Lawsuit

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

September 28, 2023

From BioNTech SE

Via GlobeNewswire

Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs ↗

September 27, 2023

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...

Via Benzinga

DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer ↗

September 27, 2023

The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight.

Via InvestorPlace

Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means? ↗

September 20, 2023

As the U.S.

Via Benzinga

With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock? ↗

September 20, 2023

All three companies should benefit from increased COVID-19 booster sales.

Via The Motley Fool

Pancreatic Cancer Battle Boosted by $200M VC Firm

September 19, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:MACK),(NASDAQ:INCY),(NASDAQ:MRTX),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

September 18, 2023

From BioNTech SE

Via GlobeNewswire

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.